Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents

This publication has 40 references indexed in Scilit:

• Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
  American Heart Journal, 2006
• Vascular remodeling and protease inhibition—bench to bedside
  Cardiovascular Research, 2006
• Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women
  International Journal of Obesity, 2005
• Elevation of Plasma Matrix Metalloproteinase-9 in the Culprit Coronary Artery in Patients With Acute Myocardial Infarction Clinical Evidence From Distal Protection
  Circulation Journal, 2005
• Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
  Physiological Reviews, 2005
• TIMPs, MMPs and cardiovascular disease
  European Heart Journal, 2004
• Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment
  Journal of Human Hypertension, 2003
• Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension.
  International Journal of Cardiology, 2000
• Overweight and obesity in preschool children from developing countries
  International Journal of Obesity, 2000
• Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000